Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration.

Inker, Lesley A; Grams, Morgan E; Guðmundsdóttir, Hrefna; McEwan, Phil; Friedman, Robert; Thompson, Aliza; Weiner, Daniel E; Willis, Kerry; Heerspink, Hiddo J L

Inker, Lesley A; Grams, Morgan E; Guðmundsdóttir, Hrefna; McEwan, Phil; Friedman, Robert; Thompson, Aliza; Weiner, Daniel E; Willis, Kerry; Heerspink, Hiddo J L.

Afiliación

Inker LA; Division of Nephrology, Tufts Medical Center, Boston, Massachusetts. Electronic address: linker@tuftsmedicalcenter.org.
Grams ME; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Guðmundsdóttir H; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
McEwan P; Health Economics and Outcomes Research Limited, Cardiff, United Kingdom.
Friedman R; National Kidney Foundation, New York, New York.
Thompson A; Division of Cardiology and Nephrology, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
Weiner DE; Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.
Willis K; National Kidney Foundation, New York, New York.
Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; George Institute for Global Health, Sydney, Australia.

Am J Kidney Dis ; 80(4): 513-526, 2022 10.

Article en En | MEDLINE | ID: mdl-35970679

Asunto(s)

Insuficiencia Renal Crónica; Biomarcadores; Progresión de la Enfermedad; Tasa de Filtración Glomerular; Humanos; Riñón; Insuficiencia Renal Crónica/terapia; Estados Unidos; United States Food and Drug Administration

Palabras clave

Adverse events; CKD progression; albuminuria; chronic kidney disease (CKD); clinical trials; cost-effectiveness; early CKD; glomerular filtration rate (GFR); kidney failure; patient perspectives; prediction models; prevention; renal failure; risk factor; surrogate end points

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Am J Kidney Dis Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google